Procter & Gamble Health Limited

NSE PGHL.NS

Procter & Gamble Health Limited Dividend Per Share for the year ending June 30, 2024: USD 3.00

Procter & Gamble Health Limited Dividend Per Share is USD 3.00 for the year ending June 30, 2024, a 335.72% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.

Procter & Gamble Health Limited Dividend Per Share for the year ending June 30, 2023 was USD 0.69, a -68.20% change year over year.
Procter & Gamble Health Limited Dividend Per Share for the year ending June 30, 2022 was USD 2.16, a -30.00% change year over year.
Procter & Gamble Health Limited Dividend Per Share for the year ending June 30, 2021 was USD 3.09, a -56.08% change year over year.
Procter & Gamble Health Limited Dividend Per Share for the year ending June 30, 2020 was USD 7.04, a 3,170.93% change year over year.

Key data

Date	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)

NSE: PGHL.NS

Procter & Gamble Health Limited

CEO	Mr. Milind Vasant Thatte M.B.A.
IPO Date	July 1, 2002
Location	India
Headquarters	Godrej One
Employees	1,407
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka, Nepal, Myanmar, and Maldives. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.

Key trends

Past 5 years